{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:27:56Z","timestamp":1783114076627,"version":"3.54.6"},"reference-count":124,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.3892\/br.2017.927","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T09:39:35Z","timestamp":1497433175000},"page":"105-114","source":"Crossref","is-referenced-by-count":27,"title":["Unraveling the genes implicated in Alzheimer's disease"],"prefix":"10.3892","volume":"7","author":[{"given":"Mohan","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilasha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhuti","family":"Upreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanti Chamling","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"key":"key20180107142143_b1-br-0-0-927","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: Back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"key20180107142143_b2-br-0-0-927","doi-asserted-by":"crossref","first-page":"a006296","DOI":"10.1101\/cshperspect.a006296","article-title":"The genetics of Alzheimer disease","volume":"2","author":"Tanzi","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20180107142143_b3-br-0-0-927","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"key20180107142143_b4-br-0-0-927","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.exger.2012.07.009","article-title":"Expression and function of APP and its metabolites outside the central nervous system","volume":"48","author":"Puig","year":"2013","journal-title":"Exp Gerontol"},{"key":"key20180107142143_b5-br-0-0-927","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","article-title":"The secretases: Enzymes with therapeutic potential in Alzheimer disease","volume":"6","author":"De Strooper","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"key20180107142143_b6-br-0-0-927","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/emmm.201100138","article-title":"Amyloid precursor protein mutation E682K at the alternative \u03b2-secretase cleavage \u03b2'-site increases A\u03b2 generation","volume":"3","author":"Zhou","year":"2011","journal-title":"EMBO Mol Med"},{"key":"key20180107142143_b7-br-0-0-927","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt211","article-title":"The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation","volume":"5","author":"Zhang","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"key20180107142143_b8-br-0-0-927","doi-asserted-by":"crossref","first-page":"9758","DOI":"10.1073\/pnas.1218402110","article-title":"Proliferation of amyloid-\u03b242 aggregates occurs through a secondary nucleation mechanism","volume":"110","author":"Cohen","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107142143_b9-br-0-0-927","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jnen\/60.11.1051","article-title":"Cotton wool plaques in non-familial late-onset Alzheimer disease","volume":"60","author":"Le","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20180107142143_b10-br-0-0-927","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2174\/156720501209151019105834","article-title":"The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression modulates sphingosine levels and transcription of the amyloid precursor protein (APP) gene","volume":"12","author":"Davis","year":"2015","journal-title":"Curr Alzheimer Res"},{"key":"key20180107142143_b11-br-0-0-927","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2004.09.011","article-title":"ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease","volume":"18","author":"Mac\u00e9","year":"2005","journal-title":"Neurobiol Dis"},{"key":"key20180107142143_b12-br-0-0-927","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1126\/science.290.5500.2303","article-title":"Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees","volume":"290","author":"Ertekin-Taner","year":"2000","journal-title":"Science"},{"key":"key20180107142143_b13-br-0-0-927","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1093\/hmg\/ddm244","article-title":"Japanese genetic study consortium for Alzeheimer's disease: Genetic association of CTNNA3 with late-onset Alzheimer's disease in females","volume":"16","author":"Miyashita","year":"2007","journal-title":"Hum Mol Genet"},{"key":"key20180107142143_b14-br-0-0-927","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.10507","article-title":"PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease","volume":"53","author":"Dermaut","year":"2003","journal-title":"Ann Neurol"},{"key":"key20180107142143_b15-br-0-0-927","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000130198.72589.69","article-title":"Prion protein codon 129 polymorphism and risk of Alzheimer disease","volume":"63","author":"Riemenschneider","year":"2004","journal-title":"Neurology"},{"key":"key20180107142143_b16-br-0-0-927","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","article-title":"Apolipoprotein E in Alzheimer's disease: An update","volume":"37","author":"Yu","year":"2014","journal-title":"Annu Rev Neurosci"},{"key":"key20180107142143_b17-br-0-0-927","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/bj3060599","article-title":"Fibrillogenesis in Alzheimer's disease of amyloid \u03b2 peptides and apolipoprotein E","volume":"306","author":"Castano","year":"1995","journal-title":"Biochem J"},{"key":"key20180107142143_b18-br-0-0-927","first-page":"1030","article-title":"Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro","volume":"145","author":"Wisniewski","year":"1994","journal-title":"Am J Pathol"},{"key":"key20180107142143_b19-br-0-0-927","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol"},{"key":"key20180107142143_b20-br-0-0-927","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/humu.20138","article-title":"Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease","volume":"25","author":"Li","year":"2005","journal-title":"Hum Mutat"},{"key":"key20180107142143_b21-br-0-0-927","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.exger.2013.01.013","article-title":"APBB2 genetic polymorphisms are associated with severe cognitive impairment in centenarians","volume":"48","author":"Golanska","year":"2013","journal-title":"Exp Gerontol"},{"key":"key20180107142143_b22-br-0-0-927","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10048-003-0157-9","article-title":"Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2","volume":"4","author":"Finckh","year":"2003","journal-title":"Neurogenetics"},{"key":"key20180107142143_b23-br-0-0-927","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajmg.b.30403","article-title":"Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits","volume":"144B","author":"Ozturk","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"key20180107142143_b24-br-0-0-927","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1533317513494450","article-title":"Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease","volume":"28","author":"Wu","year":"2013","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"key20180107142143_b25-br-0-0-927","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/77153","article-title":"Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts","volume":"25","author":"Paloneva","year":"2000","journal-title":"Nat Genet"},{"key":"key20180107142143_b26-br-0-0-927","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe1213157","article-title":"Variant TREM2 as risk factor for Alzheimer's disease","volume":"368","author":"Neumann","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180107142143_b27-br-0-0-927","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"Alzheimer Genetic Analysis Group: TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180107142143_b28-br-0-0-927","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/cge.12108","article-title":"TREM2: A new risk factor for Alzheimer's disease","volume":"83","author":"Singaraja","year":"2013","journal-title":"Clin Genet"},{"key":"key20180107142143_b29-br-0-0-927","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180107142143_b30-br-0-0-927","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","article-title":"TREM2 and the neuroimmunology of Alzheimer's disease","volume":"88","author":"Hickman","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"key20180107142143_b31-br-0-0-927","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"key20180107142143_b32-br-0-0-927","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"key20180107142143_b33-br-0-0-927","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"European Alzheimer's Disease Initiative Investigators: Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"key20180107142143_b34-br-0-0-927","doi-asserted-by":"crossref","first-page":"13540","DOI":"10.1073\/pnas.1107067108","article-title":"SNARE motif-mediated sorting of synaptobrevin by the endocytic adaptors clathrin assembly lymphoid myeloid leukemia (CALM) and AP180 at synapses","volume":"108","author":"Koo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107142143_b35-br-0-0-927","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1038\/ncomms5998","article-title":"PICALM modulates autophagy activity and tau accumulation","volume":"5","author":"Moreau","year":"2014","journal-title":"Nat Commun"},{"key":"key20180107142143_b36-br-0-0-927","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/NEN.0b013e3181f52e01","article-title":"Distribution and expression of picalm in Alzheimer disease","volume":"69","author":"Baig","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20180107142143_b37-br-0-0-927","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-9-32","article-title":"An intronic PICALM polymorphism, rs588076, is associated with allelic expression of a PICALM isoform","volume":"9","author":"Parikh","year":"2014","journal-title":"Mol Neurodegener"},{"key":"key20180107142143_b38-br-0-0-927","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archgenpsychiatry.2010.196","article-title":"The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels","volume":"68","author":"Schjeide","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"key20180107142143_b39-br-0-0-927","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0896-6273(00)00007-6","article-title":"Reelin binds alpha3beta1 integrin and inhibits neuronal migration","volume":"27","author":"Dulabon","year":"2000","journal-title":"Neuron"},{"key":"key20180107142143_b40-br-0-0-927","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0896-6273(04)00222-3","article-title":"Disabled-1-regulated adhesion of migrating neurons to radial glial fiber contributes to neuronal positioning during early corticogenesis","volume":"42","author":"Sanada","year":"2004","journal-title":"Neuron"},{"key":"key20180107142143_b41-br-0-0-927","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"CHARGE Consortium; GERAD1 Consortium; EADI1 Consortium: Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"key20180107142143_b42-br-0-0-927","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.M100857200","article-title":"Activation and functional characterization of the mosaic receptor SorLA\/LR11","volume":"276","author":"Jacobsen","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107142143_b43-br-0-0-927","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ana.21190","article-title":"Neuronal LR11\/sorLA expression is reduced in mild cognitive impairment","volume":"62","author":"Sager","year":"2007","journal-title":"Ann Neurol"},{"key":"key20180107142143_b44-br-0-0-927","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.neurobiolaging.2014.12.007","article-title":"Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease","volume":"36","author":"Louwersheimer","year":"2015","journal-title":"Neurobiol Aging"},{"key":"key20180107142143_b45-br-0-0-927","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/bi011193l","article-title":"Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells","volume":"41","author":"Sudoh","year":"2002","journal-title":"Biochemistry"},{"key":"key20180107142143_b46-br-0-0-927","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"Apo E promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"key20180107142143_b47-br-0-0-927","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am J Pathol"},{"key":"key20180107142143_b48-br-0-0-927","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/jcp.24266","article-title":"\u03b1-2-Macroglobulin: A physiological guardian","volume":"228","author":"Rehman","year":"2013","journal-title":"J Cell Physiol"},{"key":"key20180107142143_b49-br-0-0-927","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1039\/B712728F","article-title":"Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity","volume":"4","author":"Wilson","year":"2008","journal-title":"Mol Biosyst"},{"key":"key20180107142143_b50-br-0-0-927","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1074\/jbc.M807242200","article-title":"alpha2-Macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species","volume":"284","author":"Yerbury","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180107142143_b51-br-0-0-927","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1074\/mcp.M200077-MCP200","article-title":"Blood-brain barrier damage induces release of alpha2-macroglobulin","volume":"2","author":"Cucullo","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"key20180107142143_b52-br-0-0-927","doi-asserted-by":"crossref","first-page":"9668","DOI":"10.1074\/jbc.M110.167965","article-title":"Inhibition of beta2-microglobulin amyloid fibril formation by alpha2-macroglobulin","volume":"286","author":"Ozawa","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107142143_b53-br-0-0-927","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.mp.4001775","article-title":"Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures","volume":"11","author":"Kamboh","year":"2006","journal-title":"Mol Psychiatry"},{"key":"key20180107142143_b54-br-0-0-927","doi-asserted-by":"crossref","first-page":"35689","DOI":"10.1074\/jbc.M111.243147","article-title":"Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein","volume":"286","author":"Stieren","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107142143_b55-br-0-0-927","doi-asserted-by":"crossref","first-page":"32240","DOI":"10.1074\/jbc.M603106200","article-title":"Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion","volume":"281","author":"Hiltunen","year":"2006","journal-title":"J Biol Chem"},{"key":"key20180107142143_b56-br-0-0-927","first-page":"215","article-title":"Nuclear transport, oxidative stress, and neurodegeneration","volume":"4","author":"Patel","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180107142143_b57-br-0-0-927","doi-asserted-by":"crossref","first-page":"13598","DOI":"10.1038\/srep13598","article-title":"The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: A meta-analysis","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"key20180107142143_b58-br-0-0-927","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/jnc.12334","article-title":"Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology","volume":"127","author":"Austin","year":"2013","journal-title":"J Neurochem"},{"key":"key20180107142143_b59-br-0-0-927","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/518720","article-title":"A genomewide screen for late-onset Alzheimer disease in a genetically isolated Dutch population","volume":"81","author":"Liu","year":"2007","journal-title":"Am J Hum Genet"},{"key":"key20180107142143_b60-br-0-0-927","doi-asserted-by":"crossref","first-page":"13503","DOI":"10.1074\/jbc.M300073200","article-title":"Structural characterization of a human cytosolic NMN\/NaMN adenylyltransferase and implication in human NAD biosynthesis","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180107142143_b61-br-0-0-927","doi-asserted-by":"crossref","first-page":"14796","DOI":"10.1074\/jbc.M114.554378","article-title":"Deficiency of nicotinamide mononucleotide adenylyltransferase 3 (nmnat3) causes hemolytic anemia by altering the glycolytic flow in mature erythrocytes","volume":"289","author":"Hikosaka","year":"2014","journal-title":"J Biol Chem"},{"key":"key20180107142143_b62-br-0-0-927","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2008.05.048","article-title":"A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk","volume":"133","author":"Dreses-Werringloer","year":"2008","journal-title":"Cell"},{"key":"key20180107142143_b63-br-0-0-927","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1074\/jbc.R109.080895","article-title":"Calcium signaling and amyloid toxicity in Alzheimer disease","volume":"285","author":"Demuro","year":"2010","journal-title":"J Biol Chem"},{"key":"key20180107142143_b64-br-0-0-927","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2010-1357","article-title":"CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model","volume":"20","author":"Boada","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b65-br-0-0-927","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2119\/molmed.2011.00154","article-title":"CALHM1 P86L polymorphism modulates CSF A\u03b2 levels in cognitively healthy individuals at risk for Alzheimer's disease","volume":"17","author":"Koppel","year":"2011","journal-title":"Mol Med"},{"key":"key20180107142143_b66-br-0-0-927","doi-asserted-by":"crossref","first-page":"e74203","DOI":"10.1371\/journal.pone.0074203","article-title":"Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis","volume":"8","author":"Rubio-Moscardo","year":"2013","journal-title":"PLoS One"},{"key":"key20180107142143_b67-br-0-0-927","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2005.04.014","article-title":"Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task","volume":"163","author":"Perez-Garc\u00eda","year":"2005","journal-title":"Behav Brain Res"},{"key":"key20180107142143_b68-br-0-0-927","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tins.2009.07.006","article-title":"Angiotensins in Alzheimer's disease - friend or foe?","volume":"32","author":"Kehoe","year":"2009","journal-title":"Trends Neurosci"},{"key":"key20180107142143_b69-br-0-0-927","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1460-9568.2005.03912.x","article-title":"The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide","volume":"21","author":"Oba","year":"2005","journal-title":"Eur J Neurosci"},{"key":"key20180107142143_b70-br-0-0-927","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jagp.2012.08.017","article-title":"Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele","volume":"22","author":"Qiu","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"key20180107142143_b71-br-0-0-927","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer's amyloid \u03b2-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J Neurochem"},{"key":"key20180107142143_b72-br-0-0-927","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JAD-2009-1074","article-title":"Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition","volume":"17","author":"Jaeger","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b73-br-0-0-927","doi-asserted-by":"crossref","first-page":"ENEURO.0006","DOI":"10.1523\/ENEURO.0006-15.2015","article-title":"LRP1 downregulates the Alzheimer's \u03b2-secretase BACE1 by modulating its intraneuronal trafficking(1,2,3)","volume":"2","author":"Tanokashira","year":"2015","journal-title":"eNeuro"},{"key":"key20180107142143_b74-br-0-0-927","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer's disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol Psychiatry"},{"key":"key20180107142143_b75-br-0-0-927","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Alzheimer's Disease Neuroimaging Initiative; CHARGE consortium; EADI1 consortium: Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"key":"key20180107142143_b76-br-0-0-927","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat Genet"},{"key":"key20180107142143_b77-br-0-0-927","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Cohorts for Heart and Aging Research in Genomic Epidemiology: Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet"},{"key":"key20180107142143_b78-br-0-0-927","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"key20180107142143_b79-br-0-0-927","doi-asserted-by":"crossref","first-page":"234","DOI":"10.12659\/MSM.895622","article-title":"Associations between genetic variants in 19p13 and 19q13 regions and susceptibility to Alzheimer disease: A meta-analysis","volume":"22","author":"Bao","year":"2016","journal-title":"Med Sci Monit"},{"key":"key20180107142143_b80-br-0-0-927","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"Alzheimer Disease Neuroimaging Initiative: CD33 Alzheimer's disease locus: Altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat Neurosci"},{"key":"key20180107142143_b81-br-0-0-927","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement Receptor 1: Disease associations and therapeutic implications","volume":"46","author":"Khera","year":"2009","journal-title":"Mol Immunol"},{"key":"key20180107142143_b82-br-0-0-927","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cne.903340205","article-title":"Localization of sulfated glycoprotein-2\/clusterin mRNA in the rat brain by in situ hybridization","volume":"334","author":"Danik","year":"1993","journal-title":"J Comp Neurol"},{"key":"key20180107142143_b83-br-0-0-927","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.2011.381","article-title":"Plasma clusterin and the risk of Alzheimer disease","volume":"305","author":"Schrijvers","year":"2011","journal-title":"JAMA"},{"key":"key20180107142143_b84-br-0-0-927","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nbd.2013.02.003","article-title":"Blockage of CR1 prevents activation of rodent microglia","volume":"54","author":"Crehan","year":"2013","journal-title":"Neurobiol Dis"},{"key":"key20180107142143_b85-br-0-0-927","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and its role in innate and adaptive immune responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"key20180107142143_b86-br-0-0-927","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tig.2009.12.004","article-title":"The pursuit of susceptibility genes for Alzheimer's disease: Progress and prospects","volume":"26","author":"Sleegers","year":"2010","journal-title":"Trends Genet"},{"key":"key20180107142143_b87-br-0-0-927","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/alzrt71","article-title":"CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques","volume":"3","author":"Kok","year":"2011","journal-title":"Alzheimers Res Ther"},{"key":"key20180107142143_b88-br-0-0-927","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00439-006-0134-0","article-title":"Inactivation status of PCDH11X: Sexual dimorphisms in gene expression levels in brain","volume":"119","author":"Lopes","year":"2006","journal-title":"Hum Genet"},{"key":"key20180107142143_b89-br-0-0-927","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ng.305","article-title":"Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease","volume":"41","author":"Carrasquillo","year":"2009","journal-title":"Nat Genet"},{"key":"key20180107142143_b90-br-0-0-927","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.1074\/jbc.M412909200","article-title":"Presenilin-dependent processing and nuclear function of gamma-protocadherins","volume":"280","author":"Haas","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107142143_b91-br-0-0-927","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JAD-2006-102-311","article-title":"HFE mutations and Alzheimer's disease","volume":"10","author":"Connor","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b92-br-0-0-927","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/jmg.2003.015552","article-title":"Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease","volume":"41","author":"Robson","year":"2004","journal-title":"J Med Genet"},{"key":"key20180107142143_b93-br-0-0-927","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnagi.2013.00037","article-title":"Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases","volume":"5","author":"Mariani","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"key20180107142143_b94-br-0-0-927","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JAD-131409","article-title":"Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke","volume":"38","author":"Percy","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b95-br-0-0-927","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.neurobiolaging.2010.07.018","article-title":"Transferrin and HFE genes interact in Alzheimer's disease risk: The Epistasis Project","volume":"33","author":"Lehmann","year":"2012","journal-title":"Neurobiol Aging"},{"key":"key20180107142143_b96-br-0-0-927","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.neuroscience.2007.02.027","article-title":"Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase","volume":"146","author":"Montoya","year":"2007","journal-title":"Neuroscience"},{"key":"key20180107142143_b97-br-0-0-927","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3233\/JAD-132033","article-title":"Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration","volume":"40","author":"Suszy\u0144ska-Zajczyk","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b98-br-0-0-927","doi-asserted-by":"crossref","first-page":"27994","DOI":"10.1074\/jbc.M701984200","article-title":"Impact of two novel mutations on the structure and function of human myeloperoxidase","volume":"282","author":"Goedken","year":"2007","journal-title":"J Biol Chem"},{"key":"key20180107142143_b99-br-0-0-927","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.M807731200","article-title":"Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease","volume":"284","author":"Maki","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180107142143_b100-br-0-0-927","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3233\/JAD-131469","article-title":"Increased myeloperoxidase plasma levels in patients with Alzheimer's disease","volume":"39","author":"Tzikas","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b101-br-0-0-927","first-page":"541","article-title":"Protective mechanisms by cystatin C in neurodegenerative diseases","volume":"3","author":"Gauthier","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"key":"key20180107142143_b102-br-0-0-927","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2009-0966","article-title":"Reduced levels of amyloid-\u03b2-binding proteins in cerebrospinal fluid from Alzheimer's disease patients","volume":"16","author":"Hansson","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b103-br-0-0-927","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/00207454.2012.672502","article-title":"Meta-analysis of the cystatin C(CST3) gene G73A polymorphism and susceptibility to Alzheimer's disease","volume":"122","author":"Hua","year":"2012","journal-title":"Int J Neurosci"},{"key":"key20180107142143_b104-br-0-0-927","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-2010-1291","article-title":"Cystatin C protects neuronal cells from amyloid-beta-induced toxicity","volume":"19","author":"Tizon","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"key20180107142143_b105-br-0-0-927","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fnmol.2012.00079","article-title":"Cystatin C in Alzheimer's disease","volume":"5","author":"Kaur","year":"2012","journal-title":"Front Mol Neurosci"},{"key":"key20180107142143_b106-br-0-0-927","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00439-015-1552-7","article-title":"A missense variant in CST3 exerts a recessive effect on susceptibility to age-related macular degeneration resembling its association with Alzheimer's disease","volume":"134","author":"Butler","year":"2015","journal-title":"Hum Genet"},{"key":"key20180107142143_b107-br-0-0-927","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"key20180107142143_b108-br-0-0-927","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/hmg\/ddi241","article-title":"The H1c haplotype at the MAPT locus is associated with Alzheimer's disease","volume":"14","author":"Myers","year":"2005","journal-title":"Hum Mol Genet"},{"key":"key20180107142143_b109-br-0-0-927","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1523\/JNEUROSCI.2152-07.2007","article-title":"Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities","volume":"27","author":"Li","year":"2007","journal-title":"J Neurosci"},{"key":"key20180107142143_b110-br-0-0-927","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","article-title":"Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment","volume":"64","author":"Zhong","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"key20180107142143_b111-br-0-0-927","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajpath.2013.10.002","article-title":"High activities of BACE1 in brains with mild cognitive impairment","volume":"184","author":"Cheng","year":"2014","journal-title":"Am J Pathol"},{"key":"key20180107142143_b112-br-0-0-927","doi-asserted-by":"crossref","first-page":"929042","DOI":"10.4061\/2011\/929042","article-title":"Knockdown of BACE1-AS nonprotein-coding transcript modulates beta-amyloid-related hippocampal neurogenesis","author":"Modarresi","year":"2011","journal-title":"Int J Alzheimers Dis."},{"key":"key20180107142143_b113-br-0-0-927","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neurobiolaging.2008.04.009","article-title":"Genetic association to the amyloid plaque associated protein gene COL25A1 in Alzheimer's disease","volume":"31","author":"Forsell","year":"2010","journal-title":"Neurobiol Aging"},{"key":"key20180107142143_b114-br-0-0-927","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10048-009-0201-5","article-title":"COL25A1 triggers and promotes Alzheimer's disease-like pathology in vivo","volume":"11","author":"Tong","year":"2010","journal-title":"Neurogenetics"},{"key":"key20180107142143_b115-br-0-0-927","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.biopsych.2011.12.011","article-title":"Association of COL25A1 with comorbid antisocial personality disorder and substance dependence","volume":"71","author":"Li","year":"2012","journal-title":"Biol Psychiatry"},{"key":"key20180107142143_b116-br-0-0-927","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cell.2007.12.040","article-title":"Active caspase-1 is a regulator of unconventional protein secretion","volume":"132","author":"Keller","year":"2008","journal-title":"Cell"},{"key":"key20180107142143_b117-br-0-0-927","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"key20180107142143_b118-br-0-0-927","first-page":"518901","article-title":"Genomics of dementia: APOE- and CYP2D6-related pharmacogenetics","author":"Cacabelos","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"key20180107142143_b119-br-0-0-927","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2009.09.062","article-title":"The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study","volume":"626","author":"Bromek","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"key20180107142143_b120-br-0-0-927","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1212\/WNL.0b013e3181b6bbe3","article-title":"Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease","volume":"73","author":"Pilotto","year":"2009","journal-title":"Neurology"},{"key":"key20180107142143_b121-br-0-0-927","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000367596","article-title":"Influence of the rs1080985 single nucleotide polymorphism of the CYP2D6 gene and APOE polymorphism on the response to Donepezil treatment in patients with Alzheimer's disease in China","volume":"4","author":"Liu","year":"2014","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"key20180107142143_b122-br-0-0-927","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000113710","article-title":"Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease","volume":"5","author":"Counts","year":"2008","journal-title":"Neurodegener Dis"},{"key":"key20180107142143_b123-br-0-0-927","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1073\/pnas.061445598","article-title":"Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease","volume":"98","author":"Steiner","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107142143_b124-br-0-0-927","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1073\/pnas.0502768102","article-title":"CD147 is a regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production","volume":"102","author":"Zhou","year":"2005","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:31:28Z","timestamp":1719257488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2017.927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":124,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,6,14]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.3892\/br.2017.927"],"URL":"https:\/\/doi.org\/10.3892\/br.2017.927","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,14]]}}}